Clinical Trial Update: Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates a multi-strain probiotic to treat anxiety in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Parkinson Disease

Snippet

Sponsor: University of British Columbia | Conditions: Parkinson Disease, Anxiety | Phase 2 | Status: UNKNOWN